In a post published on October 20, 2026, OpenAI states that it has acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development, and that Orchestra's team and technology are being brought together with Rosalind, OpenAI's AI models and tools for life sciences research.
● OPEN · settles 2026-10-24
| Claim made in | OpenAI acquires Orchestra Bio (openai.com) |
| Bank record | OpenAI — see its full delivery record in the bank |
| Market opened | 2026-10-21 |
| Market type | Flash market (1–3 days) |
| Calls lock | 2026-10-23 08:00 Eastern Time (12:00 UTC) — 24 hours before the check, so nobody can call it with the answer already visible |
| Check time | 2026-10-24 08:00 Eastern Time (12:00 UTC) |
| Source of record | openai.com |
Background
OpenAI is buying its way deeper into drug development. Orchestra Bio makes a platform where biopharma teams hand the coordination work of a drug programme to AI agents: monitoring studies and campaigns, tracking what depends on what, and working out the knock-on effects when something slips, such as a failed manufacturing batch pushing back a clinical trial, so the humans can decide what to do. OpenAI is folding Orchestra's team and technology into Rosalind, its life sciences line that includes the GPT-Rosalind reasoning model and Rosalind Workbench, which connects the models to scientific tools and data for planning experiments. The logic is that the science is only half the bottleneck. A new medicine takes roughly 10 to 15 years from target discovery to approval in the United States, and much of that time is lost to programmes spread across departments and outside partners running disconnected systems. OpenAI already works with Novo Nordisk and Moderna on Rosalind; the acquisition extends the same bet from helping scientists think to helping whole programmes move. No price or terms were disclosed, and OpenAI gave no date for when Orchestra's agents will show up inside its own products.
This market exists because launch announcements are easy to make and hard to grade. Press releases describe what a company intends to ship; they rarely come back later to say whether it shipped. AI Rank Bank pulls one checkable sentence out of the coverage — the sentence above — gives it a date, and lets readers price it in public. The launch itself stays with its publisher; what lives here is the claim, the crowd's call, and eventually the receipt.
How this claim is judged
Judging criteria, fixed when the market opened: Delivered if, at the check time, OpenAI's announcement remains published stating that OpenAI has acquired Orchestra Bio and is combining its team and technology with Rosalind, and it has not been withdrawn or materially corrected. A retraction, or reporting that the acquisition was called off, does not count.
The source of record is the publisher's own page linked above. A claim about a company's product is judged against that company's public output — its product pages, documentation, changelogs and official posts — not against rumors or third-party summaries. Only yes-or-no outcomes count: partial credit is not a verdict, and a claim that needs a paragraph of excuses has already answered itself.
How readers called it
2 readers called this claim. 50% said it would deliver.
1 Will deliver · 1 Won't ship
Points reward being right against the crowd. A correct call pays 100 × (1 − the share of readers who agreed with you when you placed it), with a floor of 10: side with a 90% consensus and a win pays 10, stand alone and a win pays up to 100. Wrong calls pay nothing. The price is locked in when the call is placed, so early readers are paid for judging before the crowd forms, not for copying it.
How readers split
Share of readers saying “will deliver”: opened at 0%, now at 50%. 3 snapshots on record since 2026-10-21 — a snapshot lands whenever a call is placed, and at least hourly while the market is open.
Verdict
No verdict yet. This claim is checked on 2026-10-24 08:00 Eastern Time (12:00 UTC) against the source of record below. When the check happens, one of three stamps lands on this page permanently: delivered if the claim came true as stated, busted if it did not, or unproven if the date passes without public evidence either way. Unproven claims pay no points and do not count against any reader's hit rate.
About this market
AI Rank Bank is an AI news front page with a memory. Every launch on the homepage carries one claim like this one, with a check date. Readers call claims with points, build a public record, and climb the leaderboard. Companies build a record too: every settled claim lands on the company's bank page, where its delivery rate is simple arithmetic that nobody gets to edit afterwards. There is no money in the market — points buy bragging rights only, which keeps the incentives pointed at being right.